ENHANCING E-COMMERCE CUSTOM REGULATION FOR SEAMLESS TRADE IN EAEU: A POLICY PAPER

This policy paper provides a comprehensive analysis of the e-commerce sector within the Eurasian Economic Union (EAEU), highlighting its challenges, opportunities, and potential for driving economic growth. It sets forth a series of well-crafted policy recommendations aimed at establishing a conducive environment for e-commerce development. By implementing these measures, policymakers can fully unleash the potential of e-commerce, fostering economic growth, and advancing digital inclusion. As the e-commerce sector flourishes, it necessitates the establishment of a fair and efficient regulatory framework to facilitate smooth cross-border transactions. Addressing the custom regulation and taxation of e-commerce transactions requires collaborative efforts. Policymakers must strive to develop transparent and equitable customs and taxation systems that prevent tax evasion while easing the burden on small and medium-sized enterprises. One essential consideration is the implementation of destination-based taxation, ensuring that taxes are paid in the countries where products and services are consumed. This approach fosters fairness and discourages tax avoidance strategies. The policy paper aims to propose specific measures to enhance e-commerce custom regulation, effectively tackling the unique challenges presented by online trade. Leveraging technology and fostering international cooperation are pivotal in designing streamlined customs processes, creating an enabling environment for e-commerce growth. Such endeavors will ensure compliance, minimize illicit activities, and foster a flourishing e-commerce landscape within the EAEU

Adjuvant Therapy for Stages II and III Colon Cancer: Risk Stratification, Treatment Duration, and Future Directions

Background: To date, the role of adjuvant systemic therapy in stages ii and iii colon cancer remains a topic of interest and debate. The objective of the present review was to assess the most recent data, specifically addressing methods of risk stratification, duration of therapy, and future directions. Methods: PubMed and medline were searched for literature pertinent to adjuvant chemotherapy in either stage ii or stage iii colorectal cancer. Summary: Locoregional disease, histopathology, age, laterality, and a number of other biologic and molecular markers appear to have a role in disease risk stratification. The duration of adjuvant therapy for stage iii disease can vary based on risk factors, but use of adjuvant therapy and duration of therapy in stage ii disease remain controversial. Future directions should include genomic assays and improved study design to provide concrete evidence about the duration of adjuvant folfox or capox and about other types of chemotherapy and immunotherapy

MODERN APPROACHES IN THE DIAGNOSIS AND CONSERVING THERAPY OF ADENOMYOSIS

At this point in modern gynecology there are no uniform standards in the diagnosis and treatment of adenomyosis. This problem requires special attention, since there is a tendency to increase the incidence of this disease, especially in younger women. The paper presents the data in the literature about the different methods of diagnosis (hysteroscopy, ultrasound, MRI), and provides criteria for evaluation of these methods. Of greatest interest are the data of foreign authors on a new method of treatment of adenomyosis – magnetic resonance- guided focused ultrasound surgery